Please Wait...

Recruitment

Start Strong

Clinical trials are timeline-driven from day one. You need to find qualified patients fast.

We know how to pinpoint the most effective communication channels for your patient group to help you meet or exceed your recruitment goals – on or ahead of schedule, and within budget.

We seamlessly integrate traditional media approaches with digital strategies that:

Recruitment

  • Foster expansive patient communities through effective use of social media channels
  • Reach patients via mobile channels with content that is engaging and shareable
  • Produce high-quality content that interests and educates readers
  • Deliver locally-targeted messages to a global network

With clinical trials being conducted globally and diseases ranging from common to extremely rare, it can be difficult to locate, engage, and retain the right number of quality patients for your trial. Struggling to find and keep patients can leave you with mounting costs and delayed timelines.

Bioclinica's Patient Recruitment and Retention division solves this problem by maintaining an extensive and dynamic patient database as well as multi-faceted patient communities – all of which can be expertly tapped through our propriety applications and our unique online and social media strategies.

We will uncover the right patients for your clinical trial rapidly, and provide tools and strategies to keep them engaged so that you can conduct an efficient and cost-effective trial.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @endpts: #FDA revises draft guidance on #raredisease drug R&D https://t.co/KaNVw54MDE by @ZacharyBrennan via @RAPSorg
Bioclinica (8 hours ago)
RT @PrimeVigilance: News and Press Release - Source @EMA_News now available monthly meeting highlights from #Pharmacovigilance #RiskAssessm…
Bioclinica (8 hours ago)
RT @FDA_Drug_Info: New #FDA Draft Guidance for Industry on Rare Diseases – Common Issues in Drug Development: https://t.co/yxaGyMB7hY. http…
Bioclinica (8 hours ago)
Looking to exercise DDDM in clinical trials? Get tips on obtaining, distilling and presenting data in our new white… https://t.co/NkGrS9JnG8
Bioclinica (10 hours ago)
Is your clinical study supply chain management solution increasing the risk of stock out? Ehsan Ramezani gives pers… https://t.co/YCfP3wCvK6
Bioclinica (Yesterday)
Bioclinica's Kate Adamczuk is presenting at #HAI2019 today! Details on this and other scientific findings at HAI… https://t.co/wDQr6ldfcS
Bioclinica (Yesterday)

Latest Blogs:

Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner